NDC 68071-2886
Pioglitazone 15 mg tablet
On the label: NuCare Pharmaceuticals.Inc.. It's repackaged: NuCare Pharmaceuticals.Inc. rebottles it from Rising Pharma Holdings, Inc.'s NDC 57237-219.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Aurobindo Pharma Limited | Medchal, India | Makes it and tests it | Problems found, fixed voluntarilyJul 21, 2023 · 13 inspections, 1 with FDA action |
Repackaging site
- NuCare Pharmaceuticals,Inc., Orange, CA, United States · relabels it
Recalls
- Dec 29, 2021 · Class II · Aurobindo Pharma USA Inc.
Superpotent and Failed Tablet/Capsule Specifications
Lots: Batch # PF4520028B & PF4520028A, Exp. Date 11/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Pioglitazone: every company that makes it
- Form
- tablet
- Strength
- 15 mg
- Approval
- ANDA ANDA200268
- On the market since
- Feb 13, 2013
- Package NDCs
68071-2886-3- Official label
- DailyMed (National Library of Medicine), updated Nov 21, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?